290328-55-1 Usage
Uses
Used in Pharmaceutical Industry:
4-Methanesulfonyl-piperidine is used as a key intermediate in the synthesis of various pharmaceutical drugs for its unique structural properties. It plays a crucial role in the development of new medications, contributing to the advancement of healthcare and treatment options.
Used in Organic Chemistry Research:
4-Methanesulfonyl-piperidine is used as a valuable building block in organic chemistry research, allowing scientists to explore new chemical reactions and synthesize novel compounds. Its versatile structure makes it an attractive candidate for the development of innovative materials and applications in various fields.
Used in Chemical Synthesis:
4-Methanesulfonyl-piperidine is used as a reagent in chemical synthesis processes, enabling the creation of a diverse array of compounds with potential applications in industries such as pharmaceuticals, materials science, and agrochemicals. Its unique properties facilitate the development of new products and technologies, driving innovation and progress in these sectors.
Check Digit Verification of cas no
The CAS Registry Mumber 290328-55-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,0,3,2 and 8 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 290328-55:
(8*2)+(7*9)+(6*0)+(5*3)+(4*2)+(3*8)+(2*5)+(1*5)=141
141 % 10 = 1
So 290328-55-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2S/c1-10(8,9)6-2-4-7-5-3-6/h6-7H,2-5H2,1H3
290328-55-1Relevant articles and documents
HSP90 FAMILY PROTEIN INHIBITORS
-
Page/Page column 112, (2008/06/13)
The present invention provides Hsp90 family protein inhibitors comprising, as an active ingredient, a benzoyl compound represented by general formula (I): (wherein n represents an integer of 0 to 10; R1 represents substituted or unsubstituted lower alkoxy, substituted or unsubstituted lower alkoxycarbonyl, CONR7R8 or the like; R2 represents substituted or unsubstituted aryl, a substituted or unsubstituted aromatic heterocyclic group or the like; R3 and R5, which may be the same or different, each represent a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted lower alkenyl or the like; and R4 and R6, which may be the same or different, each represent a hydrogen atom, halogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl or the like) or a prodrug thereof, or a pharmaceutically acceptable salt of said benzoyl compound or said prodrug.
Tyrosine kinase inhibitors
-
, (2008/06/13)
The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
